TJ271
First-line Non-small-cell Lung Cancer
TJ Biopharma Co., Ltd.Phase 2
—
Rating in progress
TJ271 in First-line Non-small-cell Lung Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active